Canopy Growth Corporation (CGC) Stock
Canopy Growth stock price chart
CGC stock quote & key statistics
Canopy Growth annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $284.6M | -$262.9M | -$0.51 |
| FY2025 | $269.0M | -$598.1M | -$5.22 |
| FY2024 | $297.1M | -$657.3M | -$5.85 |
| FY2023 | $333.3M | -$3.28B | -$17.85 |
| FY2022 | $475.7M | -$310.0M | $8.92 |
Fiscal year ending March 31. Source: company filings via EODHD.
About Canopy Growth Corporation
Canopy Growth Corporation, along with its subsidiaries, specializes in the cultivation, distribution, and retail of cannabis and hemp-based products designed for both recreational and medical use, with a primary focus on markets in Canada, the United States, and Germany.
Operating under two main segments, Global Cannabis and Other Consumer Products, the company offers a diverse range of offerings including dried cannabis flower, extracts, concentrates, beverages, edibles like gummies, and vaporizer products. These products are marketed under a variety of well-known brands such as Tweed, 7ACRES, DOJA, Martha Stewart CBD, BioSteel, and Tokyo Smoke, among others.
Originally established as Tweed Marijuana Inc. and rebranded as Canopy Growth Corporation in 2015, the company has been a pioneer in the cannabis industry since its inception in 2009. Headquartered in Smiths Falls, Canada, Canopy Growth continues to expand its global footprint while driving innovation and setting industry standards in the rapidly evolving cannabis and hemp sectors.
Canopy Growth stock FAQ
What is the Canopy Growth stock ticker symbol?
Canopy Growth Corporation trades on the NASDAQ under the ticker symbol CGC.
What sector and industry is Canopy Growth in?
Canopy Growth Corporation is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
How many employees does Canopy Growth have?
Canopy Growth Corporation has about 1,128 full-time employees.
What were Canopy Growth's revenue and earnings last fiscal year?
Canopy Growth reported revenue of $284.6M and net income of -$262.9M in fiscal 2026, with earnings per share of -$0.51. Revenue grew 5.8% from the prior year.
When did Canopy Growth go public?
Canopy Growth stock began trading on April 4, 2014.
Drug Manufacturers - Specialty & Generic stocks
All Healthcare stocks →- ALKSAlkermes
- AMPHAmphastar Pharmaceuticals
- AMRXAmneal Pharmaceuticals
- ANIPANI Pharmaceuticals
- BCRXBioCryst Pharmaceuticals
- COLLCollegium Pharmaceutical
- EBSEmergent BioSolutions
- ELANElanco Animal Health
- EOLSEvolus
- HIMSHims & Hers Health
- INDVIndivior
- IRWDIronwood Pharmaceuticals
- KNSAKiniksa Pharmaceuticals
- LNTHLantheus
- NBIXNeurocrine Biosciences
- ORGOOrganogenesis
- PAHCPhibro Animal Health
- PBHPrestige Consumer Healthcare
- PCRXPacira BioSciences
- PRGOPerrigo
- SUPNSupernus Pharmaceuticals
- UTHRUnited Therapeutics
- VTRSViatris
- ZTSZoetis